“…Numerous epidemiological studies indicate, on the one hand, a sufficiently high frequency of iron deficiency anemia and associated pathological conditions [1][2][3] and, on the other hand, indicate a significant proportion of persons with subclinical manifestations of metabolic disorders of this trace element [6]. Thus, according to the results of our previous studies, up to 27% of the adult population of the metropolis have either fullfledged or subclinical (at the level of the lower quartile) serum iron deficiency [4]. These facts clearly indicate the feasibility of targeted detection and personalized correction of iron deficiency.…”